FDA reveals declining sales of antibiotics for animals

By Ashley Williams contact

- Last updated on GMT

The FDA was "encouraged" by sales trends for 2017 in its report
The FDA was "encouraged" by sales trends for 2017 in its report
Sales and distribution of all medical antimicrobials intended for use in food-producing animals within North America decreased by 33% during 2016 and 2017, figures released by the US Food and Drug Administration (FDA) have revealed.

The figures, disclosed in the FDA’s summary report on ‘Antimicrobials sold or distributed for use in food-producing animals’, reflected efforts being made to support antimicrobial stewardship, said the organisation.

As well as the 2016/2017 figures, the report outlined that domestic sales of antibiotics had fallen by 41% since 2015.

Despite the FDA stating the sales data did not reflect actual antimicrobial use, the reduction in sales volumes were having a “significant impact”​ on antibiotic reduction, it said.

The sales trends reflected by the 2017 report are very encouraging, and I’m pleased to see that the sales and distribution of these antimicrobial drugs has declined significantly the past two years​,” said FDA commissioner Scott Gottlieb.

Although the 2017 sales/distribution data being made available today can’t be used to forecast numbers for the upcoming year, we hope this downward trend will continue​.”

He added: “The data summarised in the 2017 sales/distribution report is collated from estimates of antimicrobial animal drug product sales for that year provided by the drug manufacturers and can’t be substituted for actual usage data. For example, veterinarians and animal producers may purchase antimicrobial drugs, but never actually administer them to animals, or they may administer the drugs in later years​.”

GlobalMeatNews recently published​ a piece on how antibiotic use in animals should be managed.

Related topics: Industry & Markets, United States

Related news

Follow us

Products

View more

Webinars